Viracept er blevet undersøgt i kombination med andre antiretrovirale lægemidler i to hovedundersøgelser, der omfattede 605 hiv- smittede patienter i alderen tretten år og derover.
Viracept has been studied in combination with other antiviral medicines in two main studies involving 605 patients aged 13 years or more, who were infected with HIV.